Ingmar Gorman, PhD

home / authors / ingmar-gorman-phd

Dr Gorman is a study therapist in the phase 3 clinical trial for MDMA-assisted therapy and a co-founder of Fluence, a psychedelic education company that trains mental health providers in psychedelic treatments.

Articles

MDMA

MDMA-Assisted Psychotherapy: The Science Is What Matters

Ingmar Gorman, PhD

August 12th 2024

Despite the FDA's complete response letter for MDMA-assisted psychotherapy, researchers believe the data behind this PTSD treatment is what matters most.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: May 25th 2025

Mini Quiz: Treatment for Pedophilia?

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: May 25th 2025

Poor DSM-5—So Misunderstood!

Mini Quiz: Evaluating Dementia

Published: February 11th 2021 | Updated: May 25th 2025

Mini Quiz: Evaluating Dementia

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: May 25th 2025

Mini Quiz: Methods of Suicide

Mini Quiz: Assessment of Malingering

Published: April 1st 2019 | Updated: May 25th 2025

Mini Quiz: Assessment of Malingering

Mini Quiz: Medical Catatonia

Published: May 12th 2017 | Updated: May 25th 2025

Mini Quiz: Medical Catatonia

Recent Content

schizophrenia

Coordinated Specialty Care: Paving the Way for Psychosis Recovery

Looking Ahead to the ASCP Annual Meeting With Joseph F. Goldberg, MD, and Anita H. Clayton, MD

schizophrenia

Major Changes in the Treatment of Schizophrenia: A Long Time in the Making

stormy capitol

Psychiatry’s Wrong Bet

View More Recent Content

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.